# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Jun 14, 2024

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2024-06-14
- Accepted by EDGAR: Jun 14, 2024, 17:00 ET
- Period: 2024-06-11
- Accession: 0000950170-24-073769
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/lctx-20240614.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/lctx-20240614.htm

Filed Jun 14, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-073769. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.